Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RRAS2 |
| Upstream (Parents) |
|---|
| (<<) ADAM9 → RRAS2 |
| (<<) CDK8 → RRAS2 |
| (<<) HMGCS1 → RRAS2 |
| (<<) HSPA9 → RRAS2 |
| (<<) ITGB1 → RRAS2 |
| (<<) KCTD5 → RRAS2 |
| (<<) LIMK2 → RRAS2 |
| (<<) MEF2D → RRAS2 |
| (<<) MTAP → RRAS2 |
| (<<) PFDN2 → RRAS2 |
| (<<) PGK1 → RRAS2 |
| (<<) RAB5A → RRAS2 |
| (<<) RDX → RRAS2 |
| (<<) RXRB → RRAS2 |
| (<<) RYK → RRAS2 |
| (<<) SMURF1 → RRAS2 |
| (<<) STAT3 → RRAS2 |
| (<<) STK4 → RRAS2 |
| (<<) THOC4 → RRAS2 |
| (<<) TP53 → RRAS2 |
| (<<) UBE2C → RRAS2 |
| (<<) UBE2E3 → RRAS2 |
| (<<) YWHAE → RRAS2 |
| (<<) YWHAZ → RRAS2 |
| Downstream (Children) |
|---|
| RRAS2 → ADAM17 (>>) |
| RRAS2 → ADORA2B (>>) |
| RRAS2 → AQP3 (>>) |
| RRAS2 → ATF2 (>>) |
| RRAS2 → CBFA2T3 (>>) |
| RRAS2 → DEAF1 (>>) |
| RRAS2 → E2F6 (>>) |
| RRAS2 → HRAS (>>) |
| RRAS2 → HSPC159 (>>) |
| RRAS2 → ICAM1 (>>) |
| RRAS2 → NET1 (>>) |
| RRAS2 → NMU (>>) |
| RRAS2 → NRAS (>>) |
| RRAS2 → PIK3C2B (>>) |
| RRAS2 → PLA2G4C (>>) |
| RRAS2 → PTPLA (>>) |
| RRAS2 → RND3 (>>) |
| RRAS2 → SEH1L (>>) |
| RRAS2 → SQLE (>>) |
| RRAS2 → STAT6 (>>) |
| RRAS2 → TSG101 (>>) |
| RRAS2 → UBQLN1 (>>) |
| RRAS2 → YRDC (>>) |
